Angiopoietin-1/Tie2 Activation as a Therapeutic Hypothesis for Hantavirus-Induced Vascular Permeability
Authors: Atharv Dhore
Affiliation: Independent; Aldie, United States of America
Publication date: 2026-08-03
Publication pathway: Journal Publication
Collection: NSRI Student Research Journal
NSRI Student Research Journal
Online ISSN: 3143-5653
Volume: 1 Issue: 1 Pages/article: Article 0089
PDF: Open PDF/manuscript
Abstract
Severe hantavirus infection produces extensive vascular leakage, driven by a combination of endothelial dysfunction, dysregulated inflammation, VEGF-mediated hyperpermeability, angiopoietin imbalance, and degradation of the endothelial glycocalyx. This narrative review draws on the peer-reviewed literature, with particular attention to work published between 2016 and 2026, to examine how hantavirus-induced vascular permeability arises in hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), and how Angiopoietin-1 (Ang-1)/Tie2 signaling and glycocalyx injury contribute to endothelial barrier failure. Direct hantavirus evidence shows that Ang-1 inhibits hantavirus-directed endothelial permeability in vitro and that angiopoietin dysregulation tracks with disease severity in patients; findings that Tie2 activation curbs vascular leakage in sepsis and other non-hantavirus models are mechanistically suggestive but remain inferential rather than hantavirus-specific. No hantavirus animal model or clinical trial has yet evaluated Ang-1/Tie2-directed therapy, so this review treats the approach as a testable hypothesis rather than an established or recommended treatment; confirming its therapeutic value will require dedicated hantavirus-specific animal and clinical studies.
Keywords
hantavirus, endothelial dysfunction, vascular permeability, angiopoietin, Tie2, therapeutic hypothesis
Citation
Publication Details
ISSN: Online ISSN: 3143-5653
License: Author-retained; open access display by NSRI unless a separate article license states otherwise.
Peer review status: NSRI uses editorial and scholarly review. When appropriate, manuscripts may undergo blinded review by reviewers with relevant subject knowledge.
AI disclosure: No AI disclosure is attached to this public record unless stated in the manuscript.
Conflict of interest statement: No conflict of interest statement is attached to this public record unless stated in the manuscript.
References
References are available in the manuscript PDF when provided.